Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)

NGX: NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 1.44B NGN in the quarter ending September 30, 2024, with 159.76% growth. This brings the company's revenue in the last twelve months to 3.79B, up 97.62% year-over-year. In the year 2023, Neimeth International Pharmaceuticals had annual revenue of 2.21B, down -24.31%.

• Revenue (ttm): 3.79B
• Revenue Growth: +97.62%
• P/S Ratio: 2.26
• Revenue / Employee: 18.78M
• Employees: 202
• Market Cap: 8.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%
Sep 30, 2021	3.05B	207.54M	7.31%
Sep 30, 2020	2.84B	467.81M	19.73%